These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11688968)

  • 61. [5-FU pharmacokinetic study of 5-FU hepato-arterial infusion with oral UFT].
    Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K; Ochiai T; Natui S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2109-11. PubMed ID: 12484014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of Metabolic Inhibitors on the Hepatic Disposition of 5-Fluorouracil after Application to the Rat Liver Surface.
    Shimokawa K; Wakasugi K; Tomonaga R; Utsunomiya K; Miyamoto H; Fumoto S; Nishida K
    Biol Pharm Bull; 2016; 39(3):361-7. PubMed ID: 26934928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
    Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
    Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
    J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protracted hepatic arterial infusion with low-dose cisplatin plus 5-fluorouracil for unresectable liver metastases from colorectal cancer.
    Kohnoe S; Endo K; Yamamoto M; Ikeda Y; Toh Y; Baba H; Tajima T; Okamura T
    Surgery; 2002 Jan; 131(1 Suppl):S128-34. PubMed ID: 11821799
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preoperative UFT administration for patients with advanced colorectal cancer--increased uptake of 5-fluorouracil by tumor tissue is a prognostic factor.
    Nakagoe T; Ishikawa H; Sawai T; Tsuji T; Ayabe H; Eida K; Nogawa T; Nakamura Y; Kunisaki T; Tobinaga K; Furukawa M; Ino M
    Anticancer Drugs; 2000 Mar; 11(3):155-63. PubMed ID: 10831274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Early adjuvant intraportal chemotherapy with 5-fluorouracil after hepatic resection of colorectal metastasis: a preliminary clinical and pharmacokinetic study].
    Seitz JF; Aubert C; Giovannini M; Delpero JR; Houvenaeghel G; Guerinel G; Carcassonne Y
    Bull Cancer; 1989; 76(10):1127-32. PubMed ID: 2635640
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intra-hepatic arterial drug delivery.
    Blesing CH; Kerr DJ
    J Drug Target; 1996; 3(5):341-7. PubMed ID: 8866653
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Tumor regression in long-term follow-up by administration of liposome encapsulated 5-FU. An animal experiment in WAF rats with CC-531 liver tumor].
    Pohlen U; Berger G; Jung M; Rezska R; Regenstein J; Buhr HJ
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):625-9. PubMed ID: 14518330
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer.
    Ahmad MZ; Akhter S; Anwar M; Ahmad FJ
    Mol Pharm; 2012 Nov; 9(11):2986-94. PubMed ID: 22994847
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer.
    Wattanatorn W; McLeod HL; Macklon F; Reid M; Kendle KE; Cassidy J
    Pharmacotherapy; 1997; 17(5):881-6. PubMed ID: 9324177
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer.
    Gamelin E; Delva R; Jacob J; Merrouche Y; Raoul JL; Pezet D; Dorval E; Piot G; Morel A; Boisdron-Celle M
    J Clin Oncol; 2008 May; 26(13):2099-105. PubMed ID: 18445839
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells.
    Emura T; Murakami Y; Nakagawa F; Fukushima M; Kitazato K
    Int J Mol Med; 2004 Apr; 13(4):545-9. PubMed ID: 15010854
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice.
    Stoeltzing O; Liu W; Reinmuth N; Fan F; Parry GC; Parikh AA; McCarty MF; Bucana CD; Mazar AP; Ellis LM
    Int J Cancer; 2003 Apr; 104(4):496-503. PubMed ID: 12584749
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Evaluation of hepatic toxicity following high-dose 5-FU arterial infusion chemotherapy: analysis of 42 cases of colorectal liver metastases].
    Yamano T; Takayasu Y; Nakao N; Kubota A
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Mar; 60(3):94-102. PubMed ID: 10741116
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy.
    Lim L; Gibbs P; Yip D; Shapiro JD; Dowling R; Smith D; Little A; Bailey W; Liechtenstein M
    BMC Cancer; 2005 Oct; 5():132. PubMed ID: 16225697
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics.
    Maring JG; Piersma H; van Dalen A; Groen HJ; Uges DR; De Vries EG
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):167-73. PubMed ID: 12647019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.